Best treatments for hyperlipoproteinemias
17 products may treat hyperlipoproteinemias, spanning FDA drug classes such as hmg-coa reductase inhibitor, peroxisome proliferator receptor alpha agonist, bile acid sequestrant. The current highest-rated option is crestor. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 17 drugs we list for hyperlipoproteinemias, 16 are available as lower-cost generics, spanning classes such as hmg-coa reductase inhibitor, peroxisome proliferator receptor alpha agonist, bile acid sequestrant. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hyperlipoproteinemias — so confirm the right choice with your prescriber.
Understanding hyperlipoproteinemias
"Hyperlipoproteinemias" is the clinical umbrella for disorders in which lipoproteins — the particles that carry cholesterol and triglycerides through blood — are elevated. The plural matters: this is a family of conditions, not one. Older lipid medicine sorted them by which particle is high; StatPearls (NCBI Bookshelf) notes that in the Fredrickson classification, familial hypercholesterolemia is seen in "type 2a, 2b, and 3 hyperlipidemias; however, type 2a is the most common." Two ends of the category drive most decisions. Cholesterol end: StatPearls states familial hypercholesterolemia "occurs in about 1 in 250 individuals older than 20-year-old in the United States," from defects in the LDL receptor (most common), apolipoprotein B, or PCSK9 — and that heterozygous FH "is underrecognized and commonly treated sub-optimally." MedlinePlus (NLM) adds that it is inherited in an autosomal dominant pattern, so one affected parent is enough, and "in the early years there may be no symptoms" — visible signs like xanthomas come late, which is why a lipid panel, not how you feel, finds it. Triglyceride end: per StatPearls, "the risk of pancreatitis correlates with the level of triglycerides and markedly increases with levels above 500 mg/dL," then "dramatically rises if more than 1500-2000 mg/dL." At those levels the target is preventing pancreatitis, not only heart disease — a different clock than cholesterol. General information, not medical advice.
First-line treatment
Treatment splits by which lipid is high. For LDL cholesterol, the 2018 ACC/AHA multisociety cholesterol guideline puts statins first: "Statin therapy is recommended as the first-line drug treatment for primary prevention of atherosclerotic cardiovascular disease (ASCVD)," and it includes "patient's with ages between 20 and 75 years with LDL >190 mg/dl in whom high intensity statins should be initiated." For patients the guideline classes as very high risk ASCVD, "high intensity or maximum tolerated statin is the cornerstone of therapy" — and from there it escalates by threshold rather than by symptom: "If the LDL-C threshold is ⩾70 mg/dl, ezetimibe should be added and if the patient still has a LDL-C threshold ⩾70 mg/dl or non-HDL-C ⩾100 mg/dl, adding a PCSK9 inhibitor is reasonable." When the call is genuinely close, the guideline says that "if there is still uncertainty with respect to introducing statin therapy, assessment of CAC can be offered in patients at intermediate risk to guide statin therapy." MedlinePlus (NLM) notes statins are "commonly used and are very effective" in familial hypercholesterolemia, alongside diet change. Doses are individualized by a clinician.
Top-rated picks for hyperlipoproteinemias: 1. Crestor · 2. Gemfibrozil · 3. Zocor
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $1 | View → | |
| 2 | 70/100 | Prescription | Tablet | Peroxisome Proliferator Receptor alpha Agonist | Generic | $3 | View → | |
| 3 | 70/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $1 | View → | |
| 4 | 68/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $86 | View → | |
| 5 | 68/100 | Prescription | Tablet | HMG-CoA Reductase Inhibitor | Generic | $38 | View → | |
| 6 | 66/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 7 | 64/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 8 | 64/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 9 | 64/100 | Prescription | Tablet | Peroxisome Proliferator Receptor alpha Agonist | Generic | $3 | View → | |
| 10 | 62/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $8 | View → |
Narrow by drug class
Explore the class hubs: hmg-coa reductase inhibitor · bile acid sequestrant · peroxisome proliferator receptor alpha agonist
Full ranking · 17 treatments
crestor
PrescriptionFDA-sourced
Crestor (Rosuvastatin Calcium) is a HMG-CoA reductase inhibitor used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
From ~$1.04/30· 4 forms Save up to 32% in classgemfibrozil
PrescriptionFDA-sourced
Gemfibrozil is a peroxisome proliferator receptor alpha agonist used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
~$3.09 /30
Save up to 10% in class
zocor
PrescriptionFDA-sourced
Zocor (Simvastatin) is a HMG-CoA reductase inhibitor used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
From ~$0.84/30· 5 forms
lescol xl
PrescriptionFDA-sourced
Lescol XL (Fluvastatin Sodium) is a HMG-CoA reductase inhibitor used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
From ~$75.75/30· 3 forms Save up to 99% in classpitavastatin calcium
PrescriptionFDA-sourced
Pitavastatin Calcium is a HMG-CoA reductase inhibitor used to treat Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pharmacy pays
From ~$36.01/30· 3 forms Save up to 98% in classcolestipol hydrochloride
PrescriptionFDA-sourced
Colestipol Hydrochloride is a bile acid sequestrant used to treat Coronary Artery Disease, Diarrhea, Pseudomembranous Enterocolitis, Hypercholesterolemia.
Pharmacy pays
~$20.09 /30
Save up to 58% in class- Colestid
- Flavored Colestid
- Lopid
- Colesevelam Hydrochloride
- Lovastatin
- Atorvaliq
- Flolipid
- Lipitor
- Lipofen
- Livalo
- Zypitamag
Frequently asked
- What treats hyperlipoproteinemias?
- Our catalog lists 17 products that may treat hyperlipoproteinemias, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is crestor.
- What is the best-rated treatment for hyperlipoproteinemias?
- By our independent recall-safety rating — not an efficacy measure — crestor ranks highest among the products we list for hyperlipoproteinemias. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat hyperlipoproteinemias?
- Treatments for hyperlipoproteinemias span FDA drug classes including hmg-coa reductase inhibitor, peroxisome proliferator receptor alpha agonist, bile acid sequestrant. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.